1. Home
  2. ADVB vs CASI Comparison

ADVB vs CASI Comparison

Compare ADVB & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVB
  • CASI
  • Stock Information
  • Founded
  • ADVB 2014
  • CASI 1991
  • Country
  • ADVB United States
  • CASI China
  • Employees
  • ADVB N/A
  • CASI N/A
  • Industry
  • ADVB Medical Specialities
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADVB Health Care
  • CASI Health Care
  • Exchange
  • ADVB Nasdaq
  • CASI Nasdaq
  • Market Cap
  • ADVB 20.8M
  • CASI 20.5M
  • IPO Year
  • ADVB 2025
  • CASI 1996
  • Fundamental
  • Price
  • ADVB $0.44
  • CASI $2.38
  • Analyst Decision
  • ADVB
  • CASI Strong Buy
  • Analyst Count
  • ADVB 0
  • CASI 1
  • Target Price
  • ADVB N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • ADVB 2.3M
  • CASI 3.7M
  • Earning Date
  • ADVB 08-26-2025
  • CASI 08-26-2025
  • Dividend Yield
  • ADVB N/A
  • CASI N/A
  • EPS Growth
  • ADVB N/A
  • CASI N/A
  • EPS
  • ADVB N/A
  • CASI N/A
  • Revenue
  • ADVB N/A
  • CASI $31,368,000.00
  • Revenue This Year
  • ADVB N/A
  • CASI N/A
  • Revenue Next Year
  • ADVB N/A
  • CASI N/A
  • P/E Ratio
  • ADVB N/A
  • CASI N/A
  • Revenue Growth
  • ADVB N/A
  • CASI 8.39
  • 52 Week Low
  • ADVB $0.34
  • CASI $1.09
  • 52 Week High
  • ADVB $4.10
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • ADVB N/A
  • CASI 70.81
  • Support Level
  • ADVB N/A
  • CASI $1.46
  • Resistance Level
  • ADVB N/A
  • CASI $2.03
  • Average True Range (ATR)
  • ADVB 0.00
  • CASI 0.35
  • MACD
  • ADVB 0.00
  • CASI 0.07
  • Stochastic Oscillator
  • ADVB 0.00
  • CASI 61.75

About ADVB Advanced Biomed Inc. Common Stock

Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: